| Intimation of transfer of Company''s domestic branded pharmaceutical formulation business to Auropharm Limited, a wholly owned subsidiary of the Company.
Intimation of completion of transfer of Company''s domestic branded generic pharmaceutical formulations products business to Auropharm Limited, a wholly owned subsidiary of the Company.
(As per BSE Announcement dated on: 02.07.2026) | | Powered by Capital Market - Live News |
|